Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$42.28 USD
+0.73 (1.76%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $42.25 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.32 | 0.00% |
Earnings Summary
For their last quarter, Janux Therapeutics (JANX) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 14.29%. Look out for JANX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year increase of 23.81%.
Earnings History
Price & Consensus
Zacks News for JANX
Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services